RB1 and breast cancer: RBNSig-BC–predicted groups (low, no confidence, and high) showed a gene expression profile similar to that observed in the TCGA discovery data, with enrichment of RB1-defective cancers in RBNSig-BC–high group (OR = 4, P = 0.0016, Fisher’s exact test; fig.